Profiling of donor-specific immune effector signatures in response to rituximab in a human whole blood loop assay using blood from CLL patients-Reference-Cited by-同舟云学术

Profiling of donor-specific immune effector signatures in response to rituximab in a human whole blood loop assay using blood from CLL patients

Published:2021-01 Issue: Volume:90 Page:107226
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Eltahir M.,Fletcher E.,Dynesius L.,Jarblad J.L.,Lord M.,Laurén I.,Zekarias M.,Yu X.,Cragg M.S.,Hammarström C.,Levedahl K.H.,Höglund M.,Ullenhag G.,Mattsson M.,Mangsbo S.M.

Funder

Svenska Sällskapet för Medicinsk Forskning

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference50 articles.

1. Follicular lymphoma;Carbone;Nat. Rev. Dis. Primers,2019

2. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis;Edwards;N. Engl. J. Med.,2004

3. Rituximab therapy of patients with B-cell chronic lymphocytic leukemia;Huhn;Blood,2001

4. Systematic review on infusion reactions to and infusion rate of monoclonal antibodies used in cancer treatment;Rombouts;Anticancer Res.,2020

5. Cytokine release syndrome;Yildizhan;J. Oncol. Sci.,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiplex proteomics using proximity extension assay for the identification of protein biomarkers predictive of acute graft-vs.-host disease in allogeneic hematopoietic cell transplantation;Clinical Chemistry and Laboratory Medicine (CCLM);2023-01-20

2. Determination of temporal reproducibility and variability of cancer biomarkers in serum and EDTA plasma samples using a proximity extension assay;Clinical Proteomics;2022-11-15

3. Proteomics approaches to characterize the immune responses in cancer;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2022-08

4. An Adaptable Antibody‐Based Platform for Flexible Synthetic Peptide Delivery Built on Agonistic CD40 Antibodies;Advanced Therapeutics;2022-06-14

5. Impedimetric Immunosensor for On-Site Measurement of Rituximab from Invasive and Non-Invasive Samples;Journal of The Electrochemical Society;2022-05-01